Home›CANCER

Pediatric Cancers

Integrating cutting edge genomic diagnostics and innovative pediatric therapies to deliver precise, effective care tailored specifically to the unique needs of growing children.

Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis. 

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

Overview and Definition of Pediatric Cancers

Pediatric Cancers

The overview and definition of pediatric cancers provides essential insight into a group of diseases that affect children and adolescents worldwide. Understanding these malignancies is crucial for families, caregivers, and international patients seeking specialized care. Each year, approximately 300,000 new cases are diagnosed in children under 19, highlighting the need for early detection and comprehensive treatment. This page delivers a detailed overview and definition of pediatric cancers, covering the most common types, underlying causes, diagnostic pathways, treatment options, and the supportive services offered by Liv Hospital for patients traveling from abroad.

Readers will learn how pediatric oncology differs from adult cancer care, why age‑specific approaches matter, and what resources are available to ensure a seamless experience for international families. Whether you are a parent researching options or a healthcare professional seeking a concise reference, the information below equips you with the knowledge to navigate the complex landscape of childhood cancer.

Types of Pediatric Cancers

Children develop a distinct set of cancers that differ in biology and behavior from adult malignancies. The most prevalent pediatric cancers include leukemias, brain tumors, lymphomas, and solid tumors of the bone and soft tissue. Recognizing the specific type is the first step toward effective treatment.

Major Categories

    • Leukemia – Cancer of the blood‑forming tissues, accounting for about 30% of all childhood cancers.
    • Brain and Central Nervous System Tumors – The second most common group, often presenting with headaches or neurological changes.
    • Lymphoma – Includes Hodgkin and non‑Hodgkin varieties, typically presenting with swollen lymph nodes.
    • Neuroblastoma – Arises from nerve tissue, most frequently diagnosed in infants and toddlers.
    • Wilms Tumor – A kidney cancer that primarily affects children aged 3–4 years.
    • Bone Sarcomas – Such as osteosarcoma and Ewing sarcoma, usually occurring in the long bones.
    • Soft‑Tissue Sarcomas – Include rhabdomyosarcoma, often found in the head, neck, and genitourinary tract.

Cancer Type

Typical Age Range

Key Features

 

Acute Lymphoblastic Leukemia (ALL)

2–5 years

Rapidly proliferating lymphoblasts, high cure rates with chemotherapy

Medulloblastoma

3–8 years

Most common malignant brain tumor, located in the cerebellum

Hodgkin Lymphoma

10–15 years

Painless cervical lymph node enlargement, excellent prognosis

Neuroblastoma

Infancy‑2 years

Often presents as an abdominal mass, variable behavior

Wilms Tumor

3–4 years

Unilateral kidney mass, favorable response to surgery + chemotherapy

Osteosarcoma

10–20 years

Occurs near growth plates, aggressive, requires multimodal therapy

Each cancer type demands a tailored therapeutic plan, reflecting differences in tumor biology, location, and the child’s developmental stage.

 
Icon LIV Hospital

Common Causes and Risk Factors

Embryonal Origins and Developmental Arrest

Unlike many adult cancers, pediatric cancers rarely have clear lifestyle‑related causes. Instead, genetic and environmental factors play a more prominent role. While most cases are sporadic, certain inherited syndromes and prenatal exposures increase risk.

Genetic Predispositions

  • Li-Fraumeni syndrome – Mutations in the TP53 gene raise susceptibility to multiple cancer types.
  • Neurofibromatosis type 1 (NF1) – Increases the likelihood of optic pathway gliomas and neurofibromas.
  • Retinoblastoma gene (RB1) mutations – Lead to early‑onset eye tumors and secondary sarcomas.
  • Down syndrome – Associated with a higher incidence of acute lymphoblastic leukemia.

Environmental and Prenatal Influences

  • Exposure to high‑dose radiation (e.g., therapeutic radiation in childhood) can trigger malignancies.
  • Maternal smoking or alcohol consumption during pregnancy may modestly increase risk.
  • Certain viral infections, such as Epstein‑Barr virus, are linked to specific lymphomas.

Understanding these risk factors assists clinicians in early surveillance and informs families about potential hereditary testing options.

Symptoms and Causes
Icon 1 LIV Hospital

Diagnostic Approaches in Children

The Genomic Landscape of Childhood Malignancy

Accurate diagnosis of pediatric cancers relies on a combination of clinical evaluation, imaging studies, laboratory tests, and tissue sampling. Early and precise identification enables the implementation of curative protocols.

Step by Step Diagnostic Workflow

  1. Clinical Assessment – Detailed history and physical examination focusing on constitutional symptoms (fever, weight loss) and site‑specific signs.
  2. Laboratory Tests – Complete blood count, peripheral smear, and specific tumor markers (e.g., alpha‑fetoprotein for hepatoblastoma).
  3. Imaging Modalities – Ultrasound for abdominal masses, MRI for brain tumors, CT scans for thoracic and pelvic lesions, and PET scans for metabolic activity.
  4. Biopsy and Histopathology – Core needle or surgical biopsy provides tissue for microscopic evaluation, immunohistochemistry, and molecular profiling.
  5. Molecular and Genetic Testing – Next‑generation sequencing identifies actionable mutations, guiding targeted therapy.

At Liv Hospital, a multidisciplinary team coordinates these steps to minimize delays and reduce the emotional burden on families.

Diagnosis and Staging

Treatment Modalities for Pediatric Oncology

Systemic Physiological Impact on the Growing Organism

Effective treatment of pediatric cancers combines surgery, chemotherapy, radiation therapy, and emerging targeted or cellular therapies. The choice of modality depends on tumor type, stage, and the child’s overall health.

Core Treatment Options

  • Surgery – Primary method for solid tumors; aims for complete resection with clear margins while preserving function.
  • Chemotherapy – Systemic drugs administered intravenously or orally; protocols are age‑adjusted to limit toxicity.
  • Radiation Therapy – Precision techniques such as intensity‑modulated radiation therapy (IMRT) protect surrounding healthy tissue.
  • Targeted Therapy – Agents like tyrosine kinase inhibitors act on specific molecular pathways identified through genetic testing.
  • Immunotherapy – Includes CAR‑T cell therapy for refractory leukemia and checkpoint inhibitors for selected solid tumors.
  • Stem Cell Transplant – Autologous or allogeneic transplantation for high‑risk or relapsed hematologic malignancies.

Multimodal regimens are often employed, and treatment plans are regularly reviewed by a tumor board to adapt to response and side‑effect profiles.

Treatment Details

Supportive Care and Long‑Term Follow‑Up

Beyond curative intent, pediatric oncology emphasizes supportive care to manage side effects, maintain quality of life, and monitor for late effects of therapy. A holistic approach addresses physical, emotional, and developmental needs.

Key Components of Supportive Care

  • Pain Management – Utilizes multimodal analgesia, including opioids, NSAIDs, and nerve blocks.
  • Nutritional Support – Dietitian‑guided interventions to counteract treatment‑related appetite loss and growth delays.
  • Psychosocial Services – Child psychologists, social workers, and play therapists provide coping strategies for patients and families.
  • Fertility Preservation – Cryopreservation of sperm, oocytes, or ovarian tissue before gonadotoxic therapy.
  • Rehabilitation – Physical and occupational therapy to restore function after surgery or prolonged immobilization.

Long‑Term Surveillance

Survivors require lifelong monitoring for secondary malignancies, cardiac dysfunction, endocrine disorders, and neurocognitive impacts. Structured follow‑up clinics, often coordinated through survivorship programs, ensure early detection and intervention.

Maintenance and Care

International Patient Services for Pediatric Cancer Care

Liv Hospital’s dedicated international patient program streamlines the journey for families traveling from abroad. From the moment a referral is received, a personalized care coordinator assists with every logistical and clinical detail.

Comprehensive Service Package

  • Appointment Scheduling – Direct coordination with pediatric oncology specialists to secure timely consultations.
  • Travel and Visa Assistance – Guidance on flight arrangements, medical visas, and airport transfers.
  • Interpreter and Cultural Support – Professional interpreters fluent in multiple languages ensure clear communication.
  • Accommodation Options – Partnerships with nearby hotels and family‑friendly suites, including meals tailored to dietary needs.
  • On‑Site Patient Liaison – A dedicated nurse navigator accompanies families throughout treatment, addressing questions and coordinating follow‑up.

These services are designed to reduce stress, allowing families to focus on the child’s health while receiving world‑class pediatric oncology care in a JCI‑accredited environment.

Why Choose Liv Hospital?

Liv Hospital combines cutting‑edge medical technology with a patient‑centered approach, making it a trusted destination for international families confronting pediatric cancer. Our JCI accreditation guarantees adherence to the highest safety and quality standards, while multidisciplinary teams bring expertise in oncology, surgery, radiology, and supportive care. The hospital’s 360‑degree international patient services ensure seamless coordination of medical appointments, travel logistics, and accommodation, allowing families to concentrate on recovery and well‑being.

Take the first step toward world‑class pediatric cancer care. Contact our international patient office today to arrange a personalized consultation and learn how Liv Hospital can support your child’s journey to health.

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR
Prof. MD. Adalet Demir Prof. MD. Adalet Demir Cancer
Group 346 LIV Hospital

Reviews from 9,651

4,9

Worth a look

Related Videos
Departments
Our Doctors
News

Was this article helpful?

Was this article helpful?

I didn't like it
I LIKE

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

FREQUENTLY ASKED QUESTIONS

What are the most common types of pediatric cancers?

Pediatric cancers differ from adult malignancies in both frequency and biology. Leukemia accounts for about 30% of cases, followed by brain and central nervous system tumors as the second most common group. Lymphomas, including Hodgkin and non‑Hodgkin types, also occur frequently. Solid tumors such as neuroblastoma, Wilms tumor (kidney), osteosarcoma and Ewing sarcoma (bone), and rhabdomyosarcoma (soft‑tissue) complete the spectrum. Each type has distinct age peaks, clinical presentations, and treatment protocols, making accurate classification essential for optimal therapy.

Genetic predispositions play a significant role in pediatric oncology. Li‑Fraumeni syndrome, caused by TP53 mutations, predisposes children to a wide range of tumors including sarcomas and brain cancers. Neurofibromatosis type 1 increases the likelihood of optic pathway gliomas and peripheral nerve tumors. Mutations in the RB1 gene lead to early‑onset retinoblastoma and subsequent sarcomas. Children with Down syndrome have a markedly higher incidence of acute lymphoblastic leukemia. Recognizing these syndromes enables early surveillance, genetic counseling, and sometimes prophylactic interventions.

The diagnostic workflow for childhood cancers starts with a thorough history and physical exam to identify constitutional and site‑specific symptoms. Laboratory studies include complete blood counts, tumor markers (e.g., AFP for hepatoblastoma), and metabolic panels. Imaging modalities such as ultrasound, MRI, CT, and PET scans localize and stage the disease. Definitive diagnosis requires tissue sampling via core needle or surgical biopsy, which is examined histologically and immunohistochemically. Advanced molecular testing, including next‑generation sequencing, detects actionable mutations that guide targeted therapies. Prompt, coordinated diagnostics reduce treatment delays and improve outcomes.

The hospital’s international patient services streamline the entire care journey for families traveling from abroad. A care coordinator schedules appointments with pediatric oncology specialists and arranges visa, flight, and airport transfer logistics. Professional interpreters provide language support, while culturally aware staff address dietary and religious needs. Partnerships with nearby hotels offer family‑friendly lodging and meals. A dedicated nurse navigator accompanies the family throughout treatment, handling clinical questions, coordinating follow‑up, and ensuring seamless communication between the care team and caregivers. This comprehensive package reduces stress and allows families to focus on the child’s recovery.

After completing therapy, pediatric cancer survivors enter a survivorship phase that can last a lifetime. Regular surveillance detects late effects such as secondary malignancies, cardiomyopathy from anthracycline exposure, endocrine disorders like growth hormone deficiency, and neurocognitive deficits from cranial radiation. Structured follow‑up clinics, often multidisciplinary, schedule periodic imaging, cardiac echo, hormone panels, and neuropsychological assessments. Early identification of these issues enables timely interventions, improves quality of life, and reduces morbidity. Liv Hospital’s survivorship program coordinates these services, providing a clear roadmap for families.

Spine Hospital of Louisiana
Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 71 24
liv-hospital-seeklogo
+90 530 510 71 24
Facebook-f X-twitter Instagram Youtube Linkedin-in Tiktok

How helpful was it?

helpful
GDPR
helpful
GDPR
helpful
GDPR
Contact Us
Contact Us
Explore Treatments